FAIRMOUNT FUNDS MANAGEMENT LLC Holdings
FAIRMOUNT FUNDS MANAGEMENT LLC is an investment fund managing more than 568.89M US dollars. The largest holdings include Axsome Therapeutics, Cogent Biosciences and Nuvalent. In Q3 2022 the fund bought assets of total value of 144.73M US dollars and sold assets of total value of 68.59M US dollars.
FAIRMOUNT FUNDS MANAGEMENT LLC portfolio value:
$568.89M
portfolio value
FAIRMOUNT FUNDS MANAGEMENT LLC quarter portfolio value change:
+22.93%
quarter
FAIRMOUNT FUNDS MANAGEMENT LLC 1 year portfolio value change:
-0.45%
1 year
FAIRMOUNT FUNDS MANAGEMENT LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2020 | 13136000 | 8574000 |
| Q2 2020 | 26586000 | 23840000 |
| Q3 2020 | 4349000 | 6171000 |
| Q4 2020 | 40592000 | 10523000 |
| Q1 2021 | 28743000 | 56081000 |
| Q2 2021 | 20268000 | 29970000 |
| Q3 2021 | 79735000 | 29530000 |
| Q4 2021 | 66582000 | 21498000 |
| Q2 2022 | 137883000 | 91897000 |
| Q3 2022 | 144730000 | 68589000 |
FAIRMOUNT FUNDS MANAGEMENT LLC 13F holdings
| Stock |
|---|
| Portfolio share: 14.88% Portfolio value: 84.62M Avg. open price: $39.93 Current price: $76.9 P/L: +92.59% Bought +101.22% shares Q3 2022 |
| Portfolio share: 7.24% Portfolio value: 41.16M Avg. open price: $7.49 Current price: $12.91 P/L: +72.36% Bought +76.97% shares Q2 2022 |
| Portfolio share: 7.11% Portfolio value: 40.43M Avg. open price: $15.72 Current price: $36.03 P/L: +129.18% Bought +21.24% shares Q3 2022 |
| Portfolio share: 5.63% Portfolio value: 32.04M Avg. open price: N/A Current price: $12.79 P/L: N/A Sold -23.93% shares Q3 2022 |
| Portfolio share: 5.44% Portfolio value: 30.95M Avg. open price: $135.92 Current price: $16.74 P/L: -87.68% Sold -22.51% shares Q3 2022 |
| Portfolio share: 5.28% Portfolio value: 30.05M Avg. open price: N/A Current price: $126.81 P/L: N/A N/A Q2 2022 |
| Portfolio share: 5.06% Portfolio value: 28.78M Avg. open price: $29.21 Current price: $20.37 P/L: -30.26% Bought +0.75% shares Q3 2022 |
| Portfolio share: 4.94% Portfolio value: 28.09M Avg. open price: $16.15 Current price: $27.5 P/L: +70.31% Bought +45.07% shares Q3 2022 |
| Portfolio share: 4.81% Portfolio value: 27.37M Avg. open price: $4.95 Current price: $13.94 P/L: +181.44% Bought +189.12% shares Q3 2022 |
| Portfolio share: 4.71% Portfolio value: 26.77M Avg. open price: $39.93 Current price: $76.9 P/L: +92.59% N/A Q3 2022 |
| Portfolio share: 4.56% Portfolio value: 25.95M Avg. open price: $323.75 Current price: $402.31 P/L: +24.27% Sold -40.82% shares Q2 2022 |
| Portfolio share: 4.28% Portfolio value: 24.34M Avg. open price: $54.85 Current price: $45.24 P/L: -17.52% Bought +21.13% shares Q1 2022 |
| Portfolio share: 3.85% Portfolio value: 21.90M Avg. open price: $6.33 Current price: $6.75 P/L: +6.60% Bought +54.53% shares Q3 2022 |
| Portfolio share: 3.65% Portfolio value: 20.75M Avg. open price: $2.96 Current price: $5.36 P/L: +81.10% Bought +16.11% shares Q3 2022 |
| Portfolio share: 2.20% Portfolio value: 12.50M Avg. open price: $2.55 Current price: $1.33 P/L: -47.84% Bought +46.24% shares Q3 2022 |
| Portfolio share: 2.19% Portfolio value: 12.45M Avg. open price: $14.05 Current price: $6.78 P/L: -51.74% Bought +10.27% shares Q2 2022 |
| Portfolio share: 2.16% Portfolio value: 12.3M Avg. open price: $27.18 Current price: $15.76 P/L: -42.02% Sold -35.01% shares Q2 2022 |
| Portfolio share: 2.12% Portfolio value: 12.07M Avg. open price: N/A Current price: $6.41 P/L: N/A N/A Q3 2022 |
| Portfolio share: 2.05% Portfolio value: 11.64M Avg. open price: N/A Current price: $201.86 P/L: N/A Sold -22.44% shares Q3 2022 |
| Portfolio share: 1.80% Portfolio value: 10.25M Avg. open price: $48.68 Current price: $51.19 P/L: +5.16% Sold -31.35% shares Q2 2022 |
| Portfolio share: 1.54% Portfolio value: 8.77M Avg. open price: $2.81 Current price: $2.13 P/L: -24.20% Bought +250.69% shares Q3 2022 |
| Portfolio share: 1.45% Portfolio value: 8.24M Avg. open price: N/A Current price: $10.89 P/L: N/A N/A Q3 2021 |
| Portfolio share: 1.07% Portfolio value: 6.08M Avg. open price: $4.18 Current price: $1.22 P/L: -70.83% Bought +35.12% shares Q2 2022 |
| Portfolio share: 0.66% Portfolio value: 3.73M Avg. open price: $29.37 Current price: $6.84 P/L: -76.71% Sold -22.99% shares Q3 2021 |
| Portfolio share: 0.60% Portfolio value: 3.39M Avg. open price: N/A Current price: $2.73 P/L: N/A Sold -53.86% shares Q3 2022 |
| Portfolio share: 0.57% Portfolio value: 3.26M Avg. open price: $25.08 Current price: $1.25 P/L: -95.02% Bought +22.53% shares Q2 2021 |
| Portfolio share: 0.16% Portfolio value: 901K Avg. open price: $93.5 Current price: $8.32 P/L: -91.10% Sold -16.07% shares Q4 2021 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.99 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $28.3 Current price: $68.49 P/L: +142.02% Sold -100.00% shares Q3 2022 |
Showing TOP 29 FAIRMOUNT FUNDS MANAGEMENT's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of FAIRMOUNT FUNDS MANAGEMENT LLC?
The biggest position of the FAIRMOUNT FUNDS MANAGEMENT LLC is Axsome Therapeutics, Inc. (AXSM) with 14.88% portfolio share worth of 84.63M US dollars.
Top 5 FAIRMOUNT FUNDS MANAGEMENT's holdings represent 40.29% of the portfolio:
- Axsome Therapeutics, Inc. (AXSM) – 14.88%
- Cogent Biosciences, Inc. (COGT) – 7.24%
- Nuvalent, Inc. (NUVL) – 7.11%
- BioCryst Pharmaceuticals, Inc. (BCRX) – 5.63%
- Biohaven Ltd. (BHVN) – 5.44%
Who is the portfolio manager of FAIRMOUNT FUNDS MANAGEMENT LLC?
The portfolio manager of the FAIRMOUNT FUNDS MANAGEMENT LLC is .
What is the total asset value of the FAIRMOUNT FUNDS MANAGEMENT LLC portfolio?
FAIRMOUNT FUNDS MANAGEMENT LLC total asset value (portfolio value) is 568.89M US dollars.
Who is ?
is the portfolio manager of the FAIRMOUNT FUNDS MANAGEMENT LLC.
What is (FAIRMOUNT FUNDS MANAGEMENT LLC) fund performance?
FAIRMOUNT FUNDS MANAGEMENT's quarterly performance is +22.93%, annualy -0.45%.
What is the FAIRMOUNT FUNDS MANAGEMENT LLC CIK?
FAIRMOUNT FUNDS MANAGEMENT's Central Index Key is 0001802528 .